WJA
ASPN icon

Williams Jones & Associates’s Aspen Aerogels ASPN Stock Holding History

Williams Jones & Associates’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-45,100
Closed -$455K – 384
2014
Q3 		$455K Buy
45,100
+24,200
+116% +$245K 0.02% 223
2014
Q2 		$231K Buy
+20,900
New +$227K 0.01% 294

Other funds holding ASPN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
RO
Reservoir Operations New York $13.2M AUM 10.2% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
NC
NBW Capital Boston, Massachusetts $464M AUM 21.25% 1-Year Est. Return

Williams Jones & Associates's ASPN Position: Q4 2014 in Review

Williams Jones & Associates sold out of Aspen Aerogels (ASPN) in Q4 2014, closing a stake of 45,100 shares — an estimated $455K sold.

Williams Jones & Associates first reported a position in ASPN in Q2 2014 and held it in 2 quarters. The position peaked at $455K in Q3 2014. 38 funds tracked by Wall St. Rank hold ASPN as of Q4 2014.

  • Williams Jones & Associates reported no remaining Aspen Aerogels position as of Q4 2014 after selling out during the quarter.
  • Williams Jones & Associates sold 45,100 Aspen Aerogels shares in Q4 2014, an estimated $455K.
  • Williams Jones & Associates first reported a position in Aspen Aerogels in Q2 2014 and held it in 2 quarters.
  • Williams Jones & Associates's Aspen Aerogels position peaked at $455K in Q3 2014.
  • 38 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2014.

Based on Williams Jones & Associates's 13F filing for Q4 2014, filed 17 Feb 2015.